Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Gomeni

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorderRobert L Findling, Gianluca Nucci, Antoni A Piergies, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Clinical and Translational Science|July 26, 2019
First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology DrugVincenzo Teneggi, Veronica Novotny-Diermayr, Lay Hoon Lee, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorderRobert L Findling, Gianluca Nucci, Antoni A Piergies, et al.
Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Clinical and Translational Science|July 26, 2019
First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology DrugVincenzo Teneggi, Veronica Novotny-Diermayr, Lay Hoon Lee, et al.
Pageof 8